Bloomfield Health Insurer Cigna To Buy Express Scripts In $67 Billion Deal

Hartford Courant (CT)

March 09--Cigna Corp. and Express Scripts Holding Co. announced Thursday a $67 billion purchase by the Bloomfield health insurer in a deal that could help control health care costs as consolidation picks up in the insurance and pharmacy benefits management industries.

The combination will "drive greater affordability," improve links within health care and prescriptions, while simplifying health care for customers, the companies said Thursday.

Objectives of the deal resemble the $69 billion purchase of Aetna Inc. by CVS Health Corp., announced last December. Executives of Aetna and CVS touted their deal for linking health care, prescription coverage and CVS' Minute Clinics that broaden -- at potentially lower costs -- patient access to health care.

David Cordani, chief executive officer of Cigna, told investor analysts on a conference call that the deal with Express Scripts combines the pharmacy company's experience negotiating lower drug costs with Cigna's relationships with doctors. The result will be to expand health care access for consumers at home, the doctor's office and centers that provide infusion services.

"We love the expansion of choice," Cordani said.

The two companies said the purchase will lead to expanded consumer choice with medical, behavioral, specialty pharmacy and other health services.

The combined company will use a network of "delivery system partnerships" to connect individuals and their health care providers, "providing a more coordinated approach to an individual's health care," the companies said.

Jeffrey Loo, an analyst at CFRA Equity Research, said he sees the deal "driven by cost savings goals through greater leverage with drug firms for lower prices, rather than growth opportunities."

Leerink Research analyst Ana Gupte said in a client note that stand-alone pharmacy benefit management businesses "had no future as outsourced service providers" to large managed care organizations because controlling spending on drugs "has become a strategic imperative with rising health care costs."

Analyst Spencer Perlman of Veda Partners said the deal "makes sense strategically" for Cigna and the U.S. health care system. The industry should be better able to control costs with a merging of the management of drug and medical benefits, he said.

Express Scripts shares climbed more than 8.5 percent, closing at $79.72, while Cigna ended the day down nearly 11.5 percent, closing at $172.

When the deal closes later this year or early 2019, Cigna shareholders will own about 64 percent of the combined company, which will keep Cigna's name. Express Scripts shareholders will own about 36 percent.

Cordani will be CEO of the combined company. Tim Wentworth, president and CEO of Express Scripts, will be president and chief operating officer of Health Services.

Part of the Cigna-Express Scripts deal's price tag includes $15 billion of the St. Louis-based pharmacy company being assumed by Cigna.

Cigna last year terminated a merger agreement with Anthem Inc. after a federal judge, citing worries that market competition would be undermined, blocked the Indianapolis insurer's proposed $48 billion purchase.

Aetna, too, had been frustrated by a federal judge who killed the Hartford health insurer's proposed $37 billion purchase of Humana Inc.

Numerous deals, such as a joint venture between Hartford HealthCare and Tufts Health Plan announced last week, are being framed as attempts to deliver better, more efficient care at a lower cost.

The Affordable Care Act also is forcing health insurers and others in the industry to consolidate in response to broader federal involvement in health care and uncertainty caused by revisions in the law by Congress.

Amazon, Berkshire Hathaway and JPMorgan Chase, looking to shake up the industry, announced in January they would launch a health plan for their employees.

___

Visit The Hartford Courant (Hartford, Conn.) at www.courant.com

Distributed by Tribune Content Agency, LLC.